SODIUM (CYCLOPENTADIENYL)TRIS(DIMETHYLPHOSPHITO)CO

Modify Date: 2024-01-09 11:13:14

SODIUM (CYCLOPENTADIENYL)TRIS(DIMETHYLPHOSPHITO)CO Structure
SODIUM (CYCLOPENTADIENYL)TRIS(DIMETHYLPHOSPHITO)CO structure
Common Name SODIUM (CYCLOPENTADIENYL)TRIS(DIMETHYLPHOSPHITO)CO
CAS Number 82149-18-6 Molecular Weight 474.13900
Density N/A Boiling Point N/A
Molecular Formula C11H23CoNaO9P3 Melting Point N/A
MSDS N/A Flash Point N/A

 Names

Name Sodium(cyclopentadienyl)tris(dimethylphosphito)cobaltate(I)

 Chemical & Physical Properties

Molecular Formula C11H23CoNaO9P3
Molecular Weight 474.13900
Exact Mass 473.97800
PSA 165.33000
LogP 4.26000

 MSDS


Section 1: Product Identification
Chemical Name:Sodium (cyclopentadienyl)tris(dimethylphosphito)cobaltate (I), 98%
CAS Registry Number:82149-18-6
Formula:Na(C5H5)Co[PO(OCH3)2]3
EINECS Number:none
Chemical Family:metallocene
Synonym:Sodiumtris(dimethylphosphito)(cyclopentadienyl)cobaltate (I)

Section 2: Composition and Information on Ingredients
IngredientCAS NumberPercentACGIH (TWA)OSHA (PEL)
Title Compound82149-18-6100%0.02mg/m3 (as Co)no data

Section 3: Hazards Identification
Irritating to skin, eyes and respiratory tract. Cobalt compounds can cause lung disease, dermatitis,
Emergency Overview:
polycythemia, congestive failure, pain, vomiting, deafness, and enlargement of the thyroid.
Primary Routes of Exposure:Skin and eyes, ingestion and dust inhalation.
Eye Contact:Causes irritation, redness, and pain.
Skin Contact:May cause dermatitis. Causes irritation to skin. Symptoms include redness, itching, and pain.
Causes irritation to the respiratory tract. Symptoms may include coughing, shortness of breath, nausea,
Inhalation:
respiratory hypersensitivity, asthma.
Causes abdominal pain, nausea, vomiting, flushing of the face and ears, mild hypotension, rash, and ringing in
Ingestion:
the ears.
Irritating to skin, eyes and respiratory tract. Causes abdominal pain, nausea, vomiting, coughing, and
Acute Health Affects:
shortness of breath.
Repeated oral administration of cobalt salts may reduce thyroid activity, cause blood disease, and damage
Chronic Health Affects:
kidney, heart and lungs. Prolonged or repeated skin exposure may cause dermatitis.
NTP:No
IARC:No
OSHA:No

SECTION 4: First Aid Measures
Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need
Eye Exposure:
assistance in keeping their eye lids open. Get immediate medical attention.
Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if
Skin Exposure:
irritation persists.
Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty
Inhalation:
in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance.
Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce
Ingestion:
vomiting only if directed by medical personnel.

SECTION 5: Fire Fighting Measures
Flash Point:not applicable
Autoignition Temperature:none
Explosion Limits:none
Extinguishing Medium:carbon dioxide, foam or dry powder
If this product is involved in a fire, fire fighters should be equipped with a NIOSH approved positive pressure
Special Fire Fighting Procedures:
self- contained breathing apparatus and full protective clothing.
Hazardous Combustion andIf involved in a fire this material may emit toxic carbon monoxide, phosphorus pentoxide, and organic fumes.
Decomposion Products:
Unusual Fire or Explosion Hazards: No unusual fire or explosion hazards.

SECTION 6: Accidental Release Measures
Small spills can be mixed with vermiculite, sodium carbonate or other suitable non combustible adsorbent and
Spill and Leak Procedures:
swept up.

SECTION 7: Handling and Storage
Handling and Storage:Store in a cool, dry area in a tightly sealed container.

SECTION 8: Exposure Controls and Personal Protection
Eye Protection:Always wear approved safety glasses when handling a chemical substance in the laboratory.
Skin Protection:Wear protective clothing and gloves.
Ventilation:Material may form a fine dust. If possible, handle the material in an efficient fume hood.
If ventilation is not available a respirator should be worn. The use of respirators requires a Respirator
Respirator:
Protection Program to be in compliance with 29 CFR 1910.134.
Ventilation:Material may form a fine dust. If possible, handle the material in an efficient fume hood.
Additional Protection:No additional protection required.

SECTION 9: Physical and Chemical Properties
Color and Form:yellow to orange xtl.
Molecular Weight:474.14
Melting Point:no data
Boiling Point:no data
Vapor Pressure:no data
Specific Gravity:no data
Odor:none
Solubility in Water:Soluble

SECTION 10: Stability and Reactivity
Stability:air and moisture stable
Hazardous Polymerization:no hazardous polymerization
Conditions to Avoid:none
Incompatibility:oxidizing agents
Decomposition Products:Carbon monoxide, carbon dioxide, phosphorus pentoxide, organic fumes, and cobalt oxide.

SECTION 11: Toxicological Information
RTECS Data:No information available in the RTECS files.
Carcinogenic Effects:No data
Mutagenic Effects:No data
Tetratogenic Effects:No data

SECTION 12: Ecological Information
Ecological Information:No information available

SECTION 13: Disposal Considerations
Disposal:Dispose of according to local, state and federal regulations.

SECTION 14: Transportation
Shipping Name (CFR):Non-hazardous
Hazard Class (CFR):NA
Additional Hazard Class (CFR):NA
Packaging Group (CFR):NA
UN ID Number (CFR):NA
Shipping Name (IATA):Non-hazardous
Hazard Class (IATA):NA
Additional Hazard Class (IATA):NA
Packaging Group (IATA):NA
UN ID Number (IATA):NA

SECTION 15: Regulatory Information
TSCA:Not listed in the TSCA inventory.
SARA (Title 313):Title compound: See category N096 for reporting.
Second Ingredient:None


SECTION 16 - ADDITIONAL INFORMATION
N/A